Australian-US biotech Opthea Ltd has reported disappointing phase 3 results with its lead drug for vision-robbing disease wet age-related macular degeneration (AMD), throwing its future into doubt ...

Following the news of two lecanemab-related deaths reported on the eve of the Clinical Trials on Alzheimer’s Disease (CTAD) 2022 conference, Eisai has now presented the full results from its ...

In order to download their phase 1 seat allotment, he/she will require their login credentials such as DOST ID and PIN. The third allotment list is now available at the official website.

In this article, we propose a voltage-controlled oscillator (VCO) with a single three-coil transformer, featuring a common-mode (CM) resonance expansion and intrinsic differential 2nd harmonic output.

Compass Plots Path to FDA With ‘Meaningful’ Phase III Data for Psilocybin Drug in Depression Although the company withheld detailed findings from the study of treatment-resistant depression, analysts ...